The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Tapton Park Innovation Centre
Tapton, Chesterfield, Derbyshire S41 0TZ United Kingdom
The British Acoustic Neuroma Association (BANA) is a voluntary organization in the United Kingdom that is dedicated to promoting the exchange of mutual support and information among individuals affected by acoustic neuroma. Acoustic neuroma, a benign tumor of one or two of the eighth cranial nerves (auditory or vestibulocochlear nerves), usually develops within the auditory canal. The cranial nerves are the 12 nerve pairs that arise from the brain. Associated symptoms, which may vary depending upon the size and location of the tumor, may include single-sided progressive hearing loss, balance difficulties, a sensation of ringing in the ear, and facial numbness or pain. The British Acoustic Neuroma Association was established in 1993 and currently has approximately 17 chapters. The association is committed to providing understandable information about acoustic neuroma to affected individuals and family members, and encouraging and supporting a network of local groups. In addition, it is dedicated to promoting research and publishing the results of such research concerning medical, surgical, and other procedures that may help prevent or treat acoustic neuroma or assist in the rehabilitation of patients following treatment.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.